Clinical Trials for Relapsed/Refractory Indolent NHL

Find clinical trials for relapsed/refractory indolent nhl. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Study of Linperlisib (YY-20394) in Combination With Rituximab in Patients With Relapsed/Refractory Indolent NHL

NCT ID: NCT06981988

This clinical trial is studying a new treatment called Linperlisib, which will be given together with a medication called rituximab, for adults who have a type of cancer known as relapsed or refrac...

Not yet recruiting

Phase: PHASE1 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions